Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
335.64
-0.41 (-0.12%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Cencora Employees
Cencora had 46,000 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
46,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$6,883,791
Profits / Employee
$41,245
Market Cap
65.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | 22,000 | 0 | - |
| Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
| Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
| Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
| Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
| Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
| Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
| Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
| Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
| Sep 30, 2011 | 10,300 | 300 | 3.00% |
| Sep 30, 2010 | 10,000 | -300 | -2.91% |
| Sep 30, 2009 | 10,300 | -600 | -5.50% |
| Sep 30, 2008 | 10,900 | -400 | -3.54% |
| Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
| Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
| Sep 30, 2005 | 13,400 | -700 | -4.96% |
| Sep 30, 2004 | 14,100 | -700 | -4.73% |
| Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
| Sep 30, 2002 | 13,700 | 0 | - |
| Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COR News
- 12 days ago - IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes - Business Wire
- 14 days ago - The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage. - Barrons
- 22 days ago - Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release - Business Wire
- 6 weeks ago - Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 7 weeks ago - Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Cencora Appoints Mark Durcan as Chairman of Its Board of Directors - Business Wire
- 2 months ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha